Predicting Future Price Moves In BiomX Inc (PHGE)

BiomX Inc (AMEX:PHGE) does about 287.17K shares in volume on a normal day but saw 584851 shares change hands in the recent trading day. The company now has a market cap of 10.33M USD. Its current market price is $0.15, marking a decrease of -5.13% compared to the previous close of $0.16. The 52 week high reached by this stock is $0.86 whilst the lowest price level in 52 weeks is $0.14.

BiomX Inc (PHGE) has a 20-day trading average at $0.1902 and the current price is -82.69% off the 52-week high compared with 7.56% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2741 and its 200-day simple moving average is $0.3088. If we look at the stock’s price movements over the week, volatility stands at 15.15%, which decreases to 11.53% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 24.70 to suggest the stock is oversold.

The consensus objective for the share price is $2.17, suggesting that the stock has a potential upside of 93.09% over the period.

FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 15, 2021 when Ladenburg Thalmann initiated the stock to “Buy” and issued a price target of $25.

The current price level is -23.83%, -46.79%, and -52.19% away from its SMA20, SMA50, and SMA200 respectively, with the PHGE price moving above the 50-day SMA on current market day. BiomX Inc (PHGE) stock is down -19.39% over the week and -34.25% over the past month. Its price is -47.14% year-to-date and -59.23% over the past year.

To reach the target analysts have set, the stock logically needs to grow 93.09 percent from here.

Outstanding shares total 45.98M with insiders holding 10.46% of the shares and institutional holders owning 12.99% of the company’s common stock. The company has a return on investment of -72.37% and return on equity of -121.29%. The beta has a value of 1.33.